The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Pharmacologic Management of Insomnia in Children and Adolescents: Consensus Statement
Abstract
OBJECTIVE. The purpose of this work was to develop a consensus statement on the current status and future role for pharmacologic management of insomnia in children and adolescents. METHOD. The National Sleep Foundation, in collaboration with Best Practice Project Management, Inc, convened expert representatives involved in the study and treatment of pediatric insomnia and conducted a 2-day conference to examine the role of pharmacologic management of pediatric insomnia and to make recommendations regarding the development of clinical trials in this area. After a series of presentations providing background on the current knowledge of pediatric insomnia and its treatment alternatives, workgroups provided recommendations for the evaluation of pharmacologic treatment of insomnia in specific populations of children and adolescents and developed guidelines for the core methodologic issues relevant to the design of clinical trials. The group developed consensus recommendations for clinical trials in this area encompassing: (1) high-priority patient populations for research, (2) inclusion/exclusion criteria, (3) outcome measures, (4) ethical considerations unique to clinical trials involving children and adolescents, and (5) priorities for future research that will enhance the understanding of pediatric insomnia. RESULTS. Conference participants unanimously agreed that there is a need for pharmacologic management of pediatric insomnia. Furthermore, the widespread use of “hypnotic” and psychotropic medications for children in the absence of safety and efficacy data indicates a knowledge gap about the best pharmacologic practices for management of pediatric insomnia. Attendees reached consensus on methodologic issues in the study of pharmacologic treatment of pediatric insomnia including agreeing on a definition of pediatric insomnia as “repeated difficulty with sleep initiation, duration, consolidation, or quality that occurs despite age-appropriate time and opportunity for sleep and results in daytime functional impairment for the child and/or family.” It was agreed that priority should be given to insomnia studies in children with attention-deficit/hyperactivity disorder and those with pervasive developmental disorders/autism spectrum disorder. There was also agreement on the need for pharmacokinetic and pharmacodynamic studies to determine appropriate dose levels and to evaluate safety with a wide range of doses. CONCLUSIONS. The treatment of pediatric insomnia is an unmet medical need. Before appropriate pharmacologic management guidelines can be developed, rigorous, large-scale clinical trials of pediatric insomnia treatment are vitally needed to provide information to the clinician on the safety and efficacy of prescription and over-the-counter agents for the management of pediatric insomnia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sleep Disturbances in Children With Attention‐Deficit/Hyperactivity Disorder
CORKUM, P., TANNOCK, R., & MOLDOFSKY, H. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199806000-00014 · Cited by 441
Owens, J. A., Rosen, C. L., & Mindell, J. A. (2003) · PEDIATRICS · doi:10.1542/peds.111.5.e628 · Cited by 214
Sleep fragmentation in children with atopic dermatitis
Reuveni, H., Chapnick, G., Tal, A., & Tarasiuk, A. (1999) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.153.3.249 · Cited by 121
Armitage, R., Yonkers, K., Cole, D., & Rush, A. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00004 · Cited by 97
Tjon Pian Gi, C. V., Broeren, J. P. A., Starreveld, J. S., & A. Versteegh, F. G. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1207-x · Cited by 85
Actigraphic Monitoring During Sleep of Children With ADHD on Methylphenidate and Placebo
SCHWARTZ, G., AMOR, L. B., GRIZENKO, N., LAGEIX, P., BARON, C., BOIVIN, D. B., & JOOBER, R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000135802.94090.93 · Cited by 70
Cited by
Sleep Behaviors and Sleep Quality in Children with Autism Spectrum Disorders
Souders, M. C., Mason, T. B. A., Valladares, O., Bucan, M., Levy, S. E., Mandell, D. S., Weaver, T. E., & Pinto-Martin, J. (2009) · Sleep · doi:10.1093/sleep/32.12.1566 · Cited by 436
Systematic Review and Meta-Analysis of Behavioral Interventions for Pediatric Insomnia
Meltzer, L. J., & Mindell, J. A. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu041 · Cited by 383
Self-citationGringras, P., Nir, T., Breddy, J., Frydman-Marom, A., & Findling, R. L. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.09.414 · Cited by 306
Malow, B. A., Byars, K., Johnson, K., Weiss, S., Bernal, P., Goldman, S. E., Panzer, R., Coury, D. L., & Glaze, D. G. (2012) · Pediatrics · doi:10.1542/peds.2012-0900i · Cited by 275
Self-citationSleep and Sleep Disorders in Children and Adolescents
Meltzer, L. J., & Mindell, J. A. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.08.004 · Cited by 253
Self-citation
Metadata
- Authors
- Mindell, J. A., Emslie, G., Blumer, J., Genel, M., Glaze, D., Ivanenko, A., Johnson, K., Rosen, C., Steinberg, F., Roth, T., & Banas, B.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-06-01
- Volume
- 117
- Issue
- 6
- Pages
- e1223-e1232
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2127916734
- Cited by
- 249
- References
- 6
- FWCI
- 19.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacologic Management of Insomnia in Children and Adolescents: Consensus Statement. https://app.cochat.ai/papers/10.1542/peds.2005-1693
- The paper
- Mindell, J. A., Emslie, G., Blumer, J., Genel, M., Glaze, D., Ivanenko, A., Johnson, K., Rosen, C., Steinberg, F., Roth, T., & Banas, B. (2006). Pharmacologic Management of Insomnia in Children and Adolescents: Consensus Statement. Pediatrics. https://doi.org/10.1542/peds.2005-1693
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.